SLC25A30: A Potential Drug Target for Cell Communication and Cell Survival

Target Name: SLC25A30

NCBI ID: G253512

SLC25A30

SLC25A30: A Potential Drug Target for Cell Communication and Cell Survival

SLC25A30, also known as SLC25A30, is a protein that is expressed in various tissues throughout the body. It is a member of the Absolute Carrier Family 25 and is located on the X chromosome. SLC25A30 has been identified as a potential drug target and has been shown to play a role in a variety of biological processes.

The Absolute Carrier Family 25 is a group of proteins that are characterized by the presence of a unique transmembrane segment and a cytoplasmic tail. This family includes proteins that are involved in various cellular processes, including intracellular signaling, neurotransmitter transport, and protein synthesis. SLC25A30 is a member of this family and is expressed in a variety of tissues, including brain, heart, and muscle.

SLC25A30 is a 30kDa protein that is expressed in various tissues, including brain, heart, and muscle. It is characterized by a unique transmembrane segment and a cytoplasmic tail. The transmembrane segment is made up of four伪-helices and is responsible for the protein's ability to interact with various signaling molecules. The cytoplasmic tail is made up of 110 amino acids and is involved in the protein's stability and localization to the cell surface.

SLC25A30 has been shown to play a role in a variety of biological processes. For example, it has been shown to be involved in intracellular signaling, specifically in the regulation of cell adhesion. SLC25A30 has been shown to interact with the protein Focal Adhesion Protein (FAAP), which is involved in the regulation of cell-cell adhesion. This interaction between SLC25A30 and FAAP suggests that the protein may play a role in the regulation of cell adhesion, which is a critical process in the development and maintenance of tissues and organs.

SLC25A30 has also been shown to be involved in the regulation of neurotransmitter transport. The neurotransmitter transport system is responsible for the delivery of neurotransmitters from the brain to the rest of the nervous system. SLC25A30 has been shown to interact with the protein TrkB, which is involved in the regulation of neurotransmitter transport. This interaction between SLC25A30 and TrkB suggests that the protein may play a role in the regulation of neurotransmitter transport.

In addition to its role in intracellular signaling and neurotransmission, SLC25A30 has also been shown to be involved in the regulation of protein synthesis. The regulation of protein synthesis is an important process that is involved in the development and maintenance of tissues and organs. SLC25A30 has been shown to interact with the protein S6, which is involved in the regulation of protein synthesis. This interaction between SLC25A30 and S6 suggests that the protein may play a role in the regulation of protein synthesis.

SLC25A30 has also been shown to be involved in a variety of other biological processes, including cell survival, cell proliferation, and cell migration. These processes are important for the development and maintenance of tissues and organs, and SLC25A30 has been shown to play a role in each of them.

In conclusion, SLC25A30 is a protein that is characterized by its unique transmembrane segment and cytoplasmic tail. It is a member of the Absolute Carrier Family 25 and has been shown to play a role in a variety of biological processes, including intracellular signaling, neurotransmission, protein synthesis, and cell survival. As a potential drug target, SLC25A30 is a promising target for future research into the regulation of these important biological processes. Further studies are needed to fully understand the role of SLC25A30 in

Protein Name: Solute Carrier Family 25 Member 30

Functions: Probable transporter

The "SLC25A30 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC25A30 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets